Single-dose Comparison of Formoterol (Oxis®) Turbuhaler® 6 µg and Formoterol Aerolizer®12 µg in Moderate to Severe Asthma: a Randomised, Crossover Study

Author： Schlimmer P.  

Publisher： Academic Press

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.15, Iss.4, 2002-08, pp. : 369-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Budesonide and Formoterol in One Pressurised Metered-Dose Inhaler in Adults and Adolescents with Moderate to Severe Asthma: A Randomised Clinical Trial

By Noonan Michael  

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2235-2254

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study

By Saito Takefumi  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 51-61

Adis International

Access to resources Recommend Favorite

Formoterol Delivered by Turbuhaler : In Pediatric Asthma

By Cheer S.M.   Warner G.T.   Easthope S.E.  

Pediatric Drugs, Vol. 5, Iss. 1, 2003-01 ,pp. : 63-68

Adis International

Access to resources Recommend Favorite

Clinical Equivalence of a Salmeterol/Fluticasone Propionate Combination Product (50/500µg) Delivered via a Chlorofluorocarbon-Free Metered-Dose Inhaler with the Diskus™ in Patients with Moderate to Severe Asthma

By van Noord J.A.  

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 243-255

Adis International

Access to resources Recommend Favorite

Formoterol Turbuhaler® 4.5 μg (Delivered Dose) has a Rapid Onset and 12-h Duration of Bronchodilation

By Selroos O.   Ekström T.  

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 2, 2002-05 ,pp. : 175-183

Academic Press

Access to resources Recommend Favorite